argenx SE (ARGX.BR)
ARGX.BR on Brussels Stock Exchange
115.70EUR
17 May 2019
115.70EUR
17 May 2019
Change (% chg)
€0.20 (+0.17%)
€0.20 (+0.17%)
Prev Close
€115.50
€115.50
Open
€115.40
€115.40
Day's High
€116.30
€116.30
Day's Low
€113.80
€113.80
Volume
84,173
84,173
Avg. Vol
117,093
117,093
52-wk High
€119.60
€119.60
52-wk Low
€54.30
€54.30
About
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)
Overall
| Beta: | 0.63 |
| Market Cap(Mil.): | €4,361.02 |
| Shares Outstanding(Mil.): | 37.69 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ARGX.BR | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 101.85 | 55.51 |
| EPS (TTM): | -1.25 | -- | -- |
| ROI: | -- | 7.41 | 11.59 |
| ROE: | -- | 7.88 | 16.33 |
Estimates